Basit öğe kaydını göster

An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

dc.contributor.authorSevindik, Ömür Gökmen
dc.contributor.authorÖzkurt, Zübeyde Nur
dc.contributor.authorBoğa, Can
dc.contributor.authorKalayoğlu Beşışık, Sevgi
dc.contributor.authorİpek, Yıldız
dc.contributor.authorGedük, Ayfer
dc.contributor.authorHarmandalı, Aybüke
dc.contributor.authorSalihoğlu, Ayşe
dc.contributor.authorHaydaroğlu Şahin, Handan
dc.contributor.authorSönmez, Mehmet
dc.contributor.authorVural, Filiz
dc.contributor.authorAkay, Olga Meltem
dc.contributor.authorKurt Yüksel, Meltem
dc.contributor.authorMaral, Senem
dc.contributor.authorEkinci, Ömer
dc.contributor.authorKırkızlar, Hakkı Onur
dc.contributor.authorTekinalp, Atakan
dc.contributor.authorDemir, Nazlı
dc.contributor.authorMerter, Mustafa
dc.contributor.authorSaydam, Güray
dc.contributor.authorAlacacıoğlu, İnci
dc.contributor.authorYeğin, Zeynep Arzu
dc.contributor.authorKasar, Mutlu
dc.contributor.authorMastanzade, Metban
dc.contributor.authorÖzsan, Güner Hayri
dc.date.accessioned2021-12-06T11:35:18Z
dc.date.available2021-12-06T11:35:18Z
dc.date.issued2021en_US
dc.identifier.citationSevindik, Ö. G., Özkurt, Z. N., Boğa, C., Kalayoğlu Beşışık, S., İpek, Y., Gedük, A. ... Özsan, G. H. (2021). An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy. Clinical Lymphoma, Myeloma & Leukemia içinde (S102-S103. ss.).en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.urihttps://hdl.handle.net/20.500.12511/8618
dc.description.abstractBackground To investigate the demographics and treatment details of the myeloma patients who were diagnosed and followed up in Turkey and received up to two lines of therapy. Methods Patients who were recorded on the database of Turkish Myeloma Registry project were included in this study if they had only received one or two lines of therapy. Demographics, patient, and disease related parameters both at the time of diagnosis and at the follow up and treatment outcomes were presented.en_US
dc.language.isoengen_US
dc.publisherCIG Media Groupen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectTurkish Myeloma Registryen_US
dc.subjectLines of Therapyen_US
dc.subjectInterim Analysisen_US
dc.titleAn interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapyen_US
dc.typeconferenceObjecten_US
dc.relation.ispartofClinical Lymphoma, Myeloma & Leukemiaen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalıen_US
dc.authorid0000-0001-9636-4113en_US
dc.identifier.volume21en_US
dc.identifier.issueSupplement:2en_US
dc.identifier.startpageS102en_US
dc.identifier.endpageS103en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.wosqualityQ3en_US


Bu öğenin dosyaları:

Thumbnail
Ad:
Sevindik-Omur-2021.pdf
Boyut:
140.1Kb
Biçim:
PDF
Açıklama:
Tam Metin / Full Text
Göster/Aç

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster